GBIO Generation Bio Co.: institutional ownership and insider trading
3 funds reported holding $179K of Generation Bio Co. in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $15.3M and net income of −$62.6M.
GBIO revenue and earnings
- Quarter ended Sep 30, 2025: revenue $1.59M, net income −$5.52M, EPS -0.82
- Quarter ended Jun 30, 2025: revenue $765K, net income −$20.9M, EPS -3.12
- Quarter ended Mar 31, 2025: revenue $8.72M, net income −$14.8M, EPS -0.22
- Quarter ended Dec 31, 2024: revenue $4.19M, net income −$21.4M, EPS 4.50
Largest institutional holders of GBIO
Recent GBIO insider trades
- Jan 13, 2025: Quinn Anthony G. bought 210,791 shares ($203K)
5%+ owners
- SymBiosis Capital Partners, LLC: 6.3% (Schedule 13G/A, filed Nov 14, 2025)
Who owns the most GBIO stock?
The largest institutional holders of Generation Bio Co. in the latest 13F filings are Nuveen Asset Management, LLC ($179K), First Horizon Advisors, Inc. ($1), HUNTINGTON NATIONAL BANK ($0).
Are insiders buying or selling GBIO?
No open-market insider buys or sells of Generation Bio Co. were reported in the last 12 months.
What was GBIO's revenue last quarter?
Generation Bio Co. reported revenue of $1.59M for the quarter ended September 30, 2025, with net income of −$5.52M.